Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30024784

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Sep 10
First author
Lancet JE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):591. doi: 10.1038/s41571-018-0080-5.
    note
    Source null
    related pmid
    30065313
    relationship
    Comment in

Authors and identifiers

  1. name
    Lancet JE
    type
    Author
  2. name
    Uy GL
    type
    Author
  3. name
    Cortes JE
    type
    Author
  4. name
    Newell LF
    type
    Author
  5. name
    Lin TL
    type
    Author
  6. name
    Ritchie EK
    type
    Author
  7. name
    Stuart RK
    type
    Author
  8. name
    Strickland SA
    type
    Author
  9. name
    Hogge D
    type
    Author
  10. name
    Solomon SR
    type
    Author
  11. name
    Stone RM
    type
    Author
  12. name
    Bixby DL
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Lancet JE
    type
    Author
  2. name
    Uy GL
    type
    Author
  3. name
    Cortes JE
    type
    Author
  4. name
    Newell LF
    type
    Author
  5. name
    Lin TL
    type
    Author
  6. name
    Ritchie EK
    type
    Author
  7. name
    Stuart RK
    type
    Author
  8. name
    Strickland SA
    type
    Author
  9. name
    Hogge D
    type
    Author
  10. name
    Solomon SR
    type
    Author
  11. name
    Stone RM
    type
    Author
  12. name
    Bixby DL
    type
    Author
bibliography ids
  1. nci-bib-e9d3803ef54d79d8dd72dbb8
book metadata
content sha256
a2a406411a1b4aca69c20cc846da443429b353c9ed056c4a1628d8a8db853f1f
document type
citation
dois
  1. 10.1200/JCO.2017.77.6112
electronic publication date
display
2018 Jul 19
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:30024784
immutable id
pubmed:30024784@a2a406411a1b4aca69c20cc846da443429b353c9ed056c4a1628d8a8db853f1f
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
26
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2684-2692
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Oct;15(10):591. doi: 10.1038/s41571-018-0080-5.
    note
    Source null
    related pmid
    30065313
    relationship
    Comment in
outcomes validated
false
pmid
30024784
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
b663e2c03680fbbac7e2bb446ac6da6e25c8cbb7aab79ee6a1e2de9f8ac10f1c
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Sep 10
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30024784/
title
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia.

Preserved source evidence · Not medical advice